Glutathione (GSH),
the constituent of the redox buffer system,
is a scavenger of reactive oxygen species (ROS), and its ratio to
oxidized glutathione (GSSG) is a key indicator of oxidative stress
in the cell. Acute myeloid leukemia (AML) is a highly aggressive hematopoietic
malignancy characterized by aberrant levels of reduced and oxidized
GSH due to oxidative stress. Therefore, the real-time, dynamic, and
highly sensitive detection of GSH/GSSG in AML cells is of great interest
for the clinical diagnosis and treatment of leukemia. The application
of genetically encoded sensors to monitor GSH/GSSG levels in AML cells
is not explored, and the underlying mechanism of how the drugs affect
GSH/GSSG dynamics remains unclear. In this study, we developed subcellular
compartment-specific sensors to monitor GSH/GSSG combined with high-resolution
fluorescence microscopy that provides insights into basal GSH/GSSG
levels in the cytosol, mitochondria, nucleus, and endoplasmic reticulum
of AML cells, in a decreasing order, revealing substantial heterogeneity
of GSH/GSSG level dynamics in different subcellular compartments.
Further, we investigated the response of GSH/GSSG ratio in AML cells
caused by Prussian blue and Fe3O4 nanoparticles,
separately and in combination with cytarabine, pointing to steep gradients.
Moreover, cytarabine and doxorubicin downregulated the GSH/GSSG levels
in different subcellular compartments. Similarly, live-cell imaging
showed a compartment-specific decrease in response to various drugs,
such as CB-839, parthenolide (PTL), and piperlongumine (PLM). The
enzymatic activity assay revealed the mechanism underlying fluctuations
in GSH/GSSG levels in different subcellular compartments mediated
by these drugs in the GSH metabolic pathway, suggesting some potential
therapeutic targets in AML cells.